CRVS

Corvus Pharmaceuticals Inc [CRVS] Investment Appeal on the Rise
Roman Campbell
Corvus Pharmaceuticals Inc’s recently made public that its Director ORBIMED ADVISORS LLC unloaded Company’s shares for reported $4.89 million on ...

CRVS stock rated an Overweight by Barclays
Daniel Torres
Corvus Pharmaceuticals Inc’s filing revealed that its Director ORBIMED ADVISORS LLC unloaded Company’s shares for reported $4.89 million on Jun ...

Taking a Closer Look At Corvus Pharmaceuticals Inc (CRVS) Following Its Recent Trade
Roman Campbell
Corvus Pharmaceuticals Inc’s recent filing unveils that its Director ORBIMED ADVISORS LLC unloaded Company’s shares for reported $4.89 million on ...

Keeping an Eye on Corvus Pharmaceuticals Inc (CRVS) After Insider Trading Activity
Samantha Gray
Corvus Pharmaceuticals Inc’s filing revealed that its Director ORBIMED ADVISORS LLC unloaded Company’s shares for reported $4.89 million on Jun ...





